Femasys, Inc. (FEMY)
1.75
0.00 (0.00%)
USD |
NASDAQ |
Oct 13, 12:39
Femasys Shareholders Equity (Quarterly) : 4.031M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.031M |
| March 31, 2026 | 7.290M |
| December 31, 2025 | 5.869M |
| September 30, 2025 | 4.556M |
| June 30, 2025 | 1.507M |
| March 31, 2025 | 1.997M |
| December 31, 2024 | 2.304M |
| September 30, 2024 | 5.970M |
| June 30, 2024 | 11.25M |
| March 31, 2024 | 15.61M |
| December 31, 2023 | 18.35M |
| September 30, 2023 | 10.44M |
| Date | Value |
|---|---|
| June 30, 2023 | 12.88M |
| March 31, 2023 | 12.36M |
| December 31, 2022 | 15.24M |
| September 30, 2022 | 18.01M |
| June 30, 2022 | 20.94M |
| March 31, 2022 | 23.49M |
| December 31, 2021 | 26.33M |
| September 30, 2021 | 28.65M |
| June 30, 2021 | 30.88M |
| March 31, 2021 | -53.56M |
| December 31, 2020 | -51.82M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 163.96M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.29M |
| Total Liabilities (Quarterly) | 8.259M |
| Debt to Equity Ratio | 1.188 |
| Current Ratio | 2.144 |
| Net Debt Paydown Yield | 4.55% |